HEXATRIONE Trademark

Trademark Overview

On Monday, November 9, 2020, a trademark application was filed for HEXATRIONE with the United States Patent and Trademark Office. The USPTO has given the HEXATRIONE trademark a serial number of 79299350. The federal status of this trademark filing is REGISTERED as of Tuesday, November 2, 2021. This trademark is owned by ETHYPHARM. The HEXATRIONE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, corticosteroids, and anti-inflammatories
hexatrione

General Information

Serial Number79299350
Word MarkHEXATRIONE
Filing DateMonday, November 9, 2020
Status700 - REGISTERED
Status DateTuesday, November 2, 2021
Registration Number6541672
Registration DateTuesday, November 2, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2021

Trademark Statements

Goods and ServicesPharmaceutical products, namely, corticosteroids, and anti-inflammatories

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameETHYPHARM
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressFR
Party NameETHYPHARM
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressFR
Party NameETHYPHARM
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Thursday, August 10, 2023INTERNATIONAL REGISTRATION RENEWED
Wednesday, July 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, May 15, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, April 22, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 22, 2022FINAL DISPOSITION PROCESSED
Wednesday, February 2, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 2, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 17, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 17, 2021PUBLISHED FOR OPPOSITION
Saturday, August 14, 2021NOTIFICATION PROCESSED BY IB
Wednesday, July 28, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 28, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 31, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 31, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, May 30, 2021REFUSAL PROCESSED BY IB
Saturday, May 8, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 5, 2021REFUSAL PROCESSED BY MPU
Wednesday, May 5, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 4, 2021NON-FINAL ACTION WRITTEN
Friday, April 16, 2021ASSIGNED TO EXAMINER
Saturday, January 9, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, January 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 4, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 3, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

hexatrione anti inflammatories corticosteroids namely products pharmaceutical